Skip to search formSkip to main content
You are currently offline. Some features of the site may not work correctly.

Blood and lymphatic system disorders

Known as: Hematopoietic and Lymphoid System Disease, Hematopoietic and Lymphoid System Disorder 
Any deviation from the normal structure or function of the blood or lymphatic system that is manifested by a characteristic set of symptoms and signs… Expand
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2017
2017
Background The effects of genetic variants related to the pharmacodynamic mechanisms of immunosuppressive drugs on their… Expand
  • table 1
  • table 2
2017
2017
Methods: RTXM83 is a proposed biosimilar developed by mAbxience S.A. to the reference medicine product rituximab (MabThera… Expand
2016
2016
AIM Term and preterm neonates are at high risk for serious adverse drug reactions (ADRs). METHODS A descriptive study of… Expand
2016
2016
Introduction The French pharmacovigilance system is coordinated by the French Medicines Agency (‘Agence nationale de securite du… Expand
Review
2014
Review
2014
Abstract Objective: Chronic myeloid leukemia (CML) treatment relies on tyrosine kinase inhibitors (TKIs), but their use can be… Expand
2013
2013
BackgroundThe nature of adverse drug reactions observed post-authorization for biopharmaceuticals differs from that observed for… Expand
  • figure 1
  • table 1
  • figure 2
  • table 2
  • figure 3
2010
2010
PURPOSE C-1311 is a member of the novel imidazoacridinone family of anticancer agents. This phase 1 trial was designed to… Expand
Highly Cited
2009
Highly Cited
2009
AbstractBackground: Reporting adverse drug reactions (ADRs) has traditionally been the sole province of healthcare professionals… Expand
  • table I
  • table II
  • table III
  • table IV
Highly Cited
2005
Highly Cited
2005
AbstractBackground: The French pharmacovigilance system is based on a network of 31 regional centres located in teaching… Expand